Details:

Alternative Title:
Int J Tuberc Lung Dis
Personal Author:
Click, E. S. ; Chirenda, J. ; Kibias, S. ; Menzies, H. J. ; Oeltmann, J. E. ; ... More +
Click, E. S. ; Chirenda, J. ; Kibias, S. ; Menzies, H. J. ; Oeltmann, J. E. ; Sentle, C. ; Muribe, T. ; Lere, T. D. ; Makombe, R. ; Bamrah, S. ; Moore, B. K. ; Cain, K. P. ; Less -
Description:
We linked results from the Fourth Botswana National Drug Resistance Survey (DRS), 2007-2008, to patient records from the national Electronic Tuberculosis Registry to determine treatment outcomes. Of 915 new patients, 651 (71%) had treatment data available. Completion or cure was achieved for 10/15 (67%, 95%CI 42-85) with isoniazid monoresistance, (6/16, 38%, 95%CI 18-61) with multidrug resistance, while 73% (391/537, 95%CI 69-76) were susceptible to first-line drugs. The analysis was limited because of unavailable treatment records and undocumented outcomes. Prospective analyses following DRSs should be considered to ensure adequate outcome data.
Subject:
[+]
Antitubercular Agents
Article
Botswana
Drug
Female
Follow-Up Studies
Humans
Isoniazid
Male
Mycobacterium Tuberculosis
Outcome
Registries
Resistance
Retrospective Studies
Survey
Treatment
Treatment Outcome
Tuberculosis, Multidrug-Resistant

Source:
Int J Tuberc Lung Dis. 18(11):1319-1322 ;
Pubmed ID:
25299864
Pubmed Central ID:
PMC5931357
Document Type:
Journal Article ;
Funding:
CC999999/Intramural CDC HHS/United States ;
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:9d1799972c14fc9913b610d4411887774e7b6a2840a9a21c3d56ff8261e76600
File Type:

Supporting Files

• 	nihms744759.nxml	xml
  	nihms744759f1.gif	gif
  	nihms744759f1.jpg	jpeg

More +